These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 35590327)

  • 1. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
    Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
    World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
    Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
    BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
    He R; Ou S; Chen S; Ding S
    Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
    Gao J; Yang S; Xie G; Pan J; Zhu F
    Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on the mechanisms of taraxerol for the treatment of gastric cancer effect based on network pharmacology.
    Huo B; Song Y; Tan B; Li J; Zhang J; Zhang F; Chang L
    Int J Immunopathol Pharmacol; 2022; 36():20587384211063962. PubMed ID: 34986036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
    Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on molecular biological mechanism of Chinese herbal medicines for the treatment of gastric precancerous lesions based on data mining and network pharmacology.
    Zhang Q; Liu N; Wu D; Xu Z; Wang Y; Wang P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):573-584. PubMed ID: 36581572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
    Wang S; Gao J; Li Q; Ming W; Fu Y; Song L; Qin J
    J Ethnopharmacol; 2020 Nov; 262():113189. PubMed ID: 32736044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound Kushen injection attenuates angiotensin II‑mediated heart failure by inhibiting the PI3K/Akt pathway.
    Wang W; Liu D; Yang L; Chen L; Miao M; Liu Y; Yin Y; Wei M; Liu G; An Y; Zheng M
    Int J Mol Med; 2023 Mar; 51(3):. PubMed ID: 36734284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Advanced Systems Pharmacology Strategy Reveals
    Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
    Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
    Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
    Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
    Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
    J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of catechin on the malignant biological behavior of gastric cancer cells through the PI3K/Akt signaling pathway.
    Ding Y; Li H; Cao S; Yu Y
    Toxicol Appl Pharmacol; 2024 Sep; 490():117036. PubMed ID: 39009138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
    Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
    Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Study to Investigate the Tumor-Suppressive Role of
    Lv L; Du J; Wang D; Yan Z
    Drug Des Devel Ther; 2024; 18():375-394. PubMed ID: 38347958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.
    Huang Z; Wu C; Zhou W; Lu S; Tan Y; Wu Z; You R; Stalin A; Guo F; Zhang J; Liu P; Wang W; Duan X; You L; Wu J
    Phytomedicine; 2023 Sep; 118():154984. PubMed ID: 37487253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.